enVVeno Medical Corporation (FRA:5HJ0)

Market Cap	6.58M -87.8%
Revenue (ttm)	n/a
Net Income	-18.72M
EPS	-32.26
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,243
Average Volume	73
Open	9.03
Previous Close	10.50
Day's Range	9.03 - 10.50
52-Week Range	8.96 - 156.80
Beta	n/a
RSI	46.92
Earnings Date	Mar 2, 2026

About enVVeno Medical

enVVeno Medical Corporation, a clinical-stage medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease. The company’s lead product is the VenoValve, a replacement venous valve for the treatment of venous chronic venous insufficiency. Its VenoValve implanted into the femoral vein of the patient in an open surgical procedure via a 5-to-6-inch incision in the upper thigh. The company also develops enVVe, a non-surgical and transcatheter-based repla...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 1999
• Employees: 37
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 5HJ0

Financial Performance

Financial numbers in USD